Avon buys Silpada Designs
This article was originally published in The Rose Sheet
Executive Summary
World's preeminent direct seller will pay $650 mil. for assets of "largest and fastest-growing" direct seller of sterling silver jewelry, with operations in the U.S., U.K. and Canada, according to July 12 release. Avon "expects Silpada to generate incremental growth by reaching new consumers and sales representatives with a higher-priced jewelry brand." CEO Andrea Jung has said firm will continue investing in direct channel to drive sustainable growth (1"The Rose Sheet" Nov. 3, 2008; Sales & Earnings In Brief). Earlier this year, Avon acquired Liz Earle Beauty Company, a U.K.-based skin-care marketer, to "broaden" Avon's leadership in anti-aging (2"The Rose Sheet" Mar. 29, 2010). Founded in 1997, Silpada has annual revenues of $230 million and employs 32,000 independent sales representatives. While Avon sells person-to-person, Silpada focuses on party-plan selling. Completion of the transaction is expected in Avon's 2010 third quarter
You may also be interested in...
M&A Chatter: Analysts Speculate On L'Oreal/Avon, P&G/Beiersdorf Deals
In the wake of Unilever's $3.7 billion acquisition of Alberto Culver, whispers of similar deals have rippled through the personal-care industry, including a possible L'Oreal bid for direct seller Avon
Sales & Earnings In Brief
Estee Lauder proceeds cautiously in 2009: The Estee Lauder Companies is cutting its outlook for sales growth in constant currencies in 2009 to 3%-5% range from 6%-8% range, despite booking $1.9 bil. in net sales for first quarter of fiscal 2009, an increase of 11% over the prior year, firm says Oct. 28. "With the threat of global recession, we are cautious about the pace of our growth for the remainder of the fiscal year," CEO William Lauder says. Firm will tighten its belt in 2009 by reducing expenditures and instituting a hiring freeze "where appropriate," according to Executive VP and CFO Rick Kunes. Such initiatives are expected to result in incremental cost savings of $150 to $200 mil. Sales growth in the quarter was driven by "strong improvements" in skin care and makeup, CEO Lauder noted. Launches including Sensuous in fragrance, Perfectionist in skin care and Turbo Lash in makeup drove revenue in North America. Sales increased sharply in Europe, the Middle East and Asia, firm says
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.